Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Other Operating Expenses (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Other Operating Expenses readings, the most recent being $7.3 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 16.83% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.8 million, a 2.27% increase, with the full-year FY2025 number at $24.8 million, up 2.27% from a year prior.
  • Other Operating Expenses hit $7.3 million in Q4 2025 for Lucid Diagnostics, up from $6.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $15.8 million in Q4 2021 to a low of -$12.5 million in Q1 2022.
  • Median Other Operating Expenses over the past 5 years was $6.0 million (2023), compared with a mean of $4.8 million.
  • The widest YoY moves for Other Operating Expenses: up 470.72% in 2022, down 241.06% in 2022.
  • Lucid Diagnostics' Other Operating Expenses stood at $15.8 million in 2021, then crashed by 54.92% to $7.1 million in 2022, then decreased by 10.73% to $6.4 million in 2023, then dropped by 1.81% to $6.3 million in 2024, then grew by 16.83% to $7.3 million in 2025.
  • The last three reported values for Other Operating Expenses were $7.3 million (Q4 2025), $6.1 million (Q3 2025), and $5.7 million (Q2 2025) per Business Quant data.